Pernix Therapeutics Holdings Inc - Ordinary Shares

(: PTXTQ)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Pernix Therapeutics Holdings Inc is a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs. It aims at underserved therapeutic areas, such as central nervous system, including neurology, pain, and psychiatry. Its products include Treximet used to treat acute migraine; Zohydro ER with BeadTek, an extended-release opioid agonist indicated used in case of severe pain; Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance, and Khedezla for major depressive disorder. Geographically all the operations are functioned though the United States, however also has a business presence in international market.

Contact Information

Website: www.pernixtx.com
Email: Matthew@lifesciadvisors.com
Main Phone: +1 800 793-2145
Address: 10 North Park Place
Address 2: Suite 201
State: NJ
City / Town: Morristown
Country: US
Postal Code: 07960

Issuer Information

Exchange: OTO
CEO: John A. Sedor
Employees: 171
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A